SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-18-000380
Filing Date
2018-01-24
Accepted
2018-01-24 11:37:24
Documents
13
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2234185z20-f.htm 20-F 4207531
2 EX-1.1 a2234185zex-1_1.htm EX-1.1 212629
3 EX-1.2 a2234185zex-1_2.htm EX-1.2 376712
4 EX-12.1 a2234185zex-12_1.htm EX-12.1 13085
5 EX-12.2 a2234185zex-12_2.htm EX-12.2 13078
6 EX-13.1 a2234185zex-13_1.htm EX-13.1 6404
7 EX-13.2 a2234185zex-13_2.htm EX-13.2 6994
8 EX-15.1 a2234185zex-15_1.htm EX-15.1 6837
9 G22202KA01I001.GIF g22202ka01i001.gif GRAPHIC 33316
10 G22202KA01I002.GIF g22202ka01i002.gif GRAPHIC 2746
11 G22202KC01I001.JPG g22202kc01i001.jpg GRAPHIC 2106
12 G22202KC07I001.JPG g22202kc07i001.jpg GRAPHIC 2061
13 G22202KWI001.JPG g22202kwi001.jpg GRAPHIC 1800
  Complete submission text file 0001047469-18-000380.txt   4902912
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-15024 | Film No.: 18544500
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences